GlobeNewswire 01/07 Grifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo® over next seven years
GlobeNewswire 17/06 Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immu...
GlobeNewswire 14/02 Grifols announces positive topline phase 3 fibrinogen clinical trial results
GlobeNewswire 03/12/2021 Marizyme Inc. Announces Results of GOAL Study Presented at 7th Annual International Coronary Congres...
GlobeNewswire 09/08/2021 ADMA Biologics Announces Commercial Availability of Expanded Vial Size Offerings for BIVIGAM® and NA...
GlobeNewswire 13/04/2021 ADMA Biologics Announces Poster Presentation Highlighting Pharmacoeconomic Burden of HIV and HBV Inf...
GlobeNewswire 09/12/2020 ADMA Biologics Enters Into $100 Million Credit Facility Loan Amendment with Perceptive Advisors
GlobeNewswire 03/03/2020 AB2 Bio Appoints Michael Soldan CEO
GlobeNewswire 10/10/2019 2019 Italian Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: Supplier Shares, Vo...
GlobeNewswire 10/10/2019 Canada Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: Supplier Shares and Strat...
GlobeNewswire 10/10/2019 United Arab Emirates Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests 2019: Suppli...
GlobeNewswire 10/10/2019 Bahrain Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests, 2019: Infectious and Gen...
GlobeNewswire 10/10/2019 Cyprus Nucleic Acid Testing Market for 100 Assays, 2019: Companies Such as Arca Biopharma, Diadexus ...
GlobeNewswire 10/10/2019 South Korean Nucleic Acid Testing Market for 100 Assays: Five-year test volume and sales forecasts
GlobeNewswire 10/10/2019 2019 Kuwait Nucleic Acid Testing Market for 100 Assays: Supplier Shares and Strategies, Country Volu...
GlobeNewswire 10/10/2019 Malta Nucleic Acid Testing Market for 100 Assays: Infectious and Genetic Diseases, Cancer, Forensic ...
GlobeNewswire 23/09/2019 ADMA Biologics to Present at 2019 Cantor Global Healthcare Conference
GlobeNewswire 22/08/2019 ADMA Biologics Announces Commercial Relaunch and its First Commercial Sales of BIVIGAM®
GlobeNewswire 08/08/2019 ADMA Biologics Reports Second Quarter and First Half 2019 Financial Results
GlobeNewswire 08/07/2019 ADMA Biologics Receives FDA Approval for License Transfers for BIVIGAM® and Nabi-HB®
GlobeNewswire 18/06/2019 Global $12.89 Bn Glucose Monitoring Markets, 2018-2019 & 2019-2025
GlobeNewswire 29/05/2019 ADMA Biologics to Present at Upcoming Investor Conferences
GlobeNewswire 10/05/2019 FDA Approves Prior Approval Supplement for BIVIGAM®
GlobeNewswire 08/05/2019 ADMA Biologics Reports First Quarter 2019 Financial Results
GlobeNewswire 03/05/2019 ADMA Biologics Elects to Draw-Down $27.5 Million in Capital from Existing Perceptive Advisors Credi...